Liquidata Share/ETF/Trust Analysis
Portfolio Holdings Detail for ISIN IE00BDZVHG35
| Stock Name / Fund | iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) |
| Issuer | Blackrock |
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
| ETF Ticker | BTEE(USD) LSE |
| ETF Ticker | BTEE.L(GBP) LSE |
Holdings detail for BGNE
| Stock Name | BeiGene Ltd |
| Ticker | BGNE(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US07725L1026 |
| LEI | 549300JFUK6FRD5MH739 |
Show aggregate BGNE holdings
News associated with BGNE
- BeiGene (NASDAQ:BGNE) Coverage Initiated by Analysts at StockNews.com
- StockNews.com assumed coverage on shares of BeiGene (NASDAQ:BGNE – Free Report) in a research report report published on Tuesday morning. The firm issued a hold rating on the stock. A number of other research firms have also recently commented on BGNE. TD Cowen boosted their target price on shares of BeiGene from $254.00 to $260.00 […] - 2025-02-05 06:38:55
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) BGNE holdings
| Date | Number of BGNE Shares Held | Base Market Value of BGNE Shares | Local Market Value of BGNE Shares | Change in BGNE Shares Held | Change in BGNE Base Value | Current Price per BGNE Share Held | Previous Price per BGNE Share Held |
|---|
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of BGNE by Blackrock for IE00BDZVHG35
Show aggregate share trades of BGNE| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2024-12-30 | SELL | -2,405 | | | 183.810* | | 204.15  Profit of 490,971 on sale |
| 2024-11-18 | SELL | -1,140 | | | 187.690* | | 209.94 Profit of 239,332 on sale |
| 2024-11-08 | SELL | -76 | | | 205.470* | | 211.42 Profit of 16,068 on sale |
| 2024-10-21 | SELL | -76 | | | 219.920* | | 0.00 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of BGNE
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2024-12-31 | 66,118 | 5 | 89,474 | 73.9% |
| 2024-12-30 | 54,222 | 488 | 83,679 | 64.8% |
| 2024-12-27 | 36,254 | 0 | 61,769 | 58.7% |
| 2024-12-26 | 29,046 | 2 | 48,070 | 60.4% |
| 2024-12-24 | 52,591 | 6 | 89,322 | 58.9% |
| 2024-12-23 | 39,702 | 0 | 107,324 | 37.0% |
| 2024-12-20 | 43,662 | 22 | 95,454 | 45.7% |
| 2024-12-19 | 54,412 | 195 | 108,690 | 50.1% |
| 2024-12-18 | 104,374 | 47 | 182,162 | 57.3% |
| 2024-12-17 | 38,196 | 1 | 123,152 | 31.0% |
| 2024-12-16 | 93,671 | 335 | 214,629 | 43.6% |
| 2024-12-13 | 49,333 | 364 | 99,392 | 49.6% |
| 2024-12-12 | 42,878 | 19 | 120,562 | 35.6% |
| 2024-12-11 | 60,384 | 749 | 184,371 | 32.8% |
| 2024-12-10 | 269,007 | 1,343 | 510,732 | 52.7% |
| 2024-12-09 | 82,187 | 1,254 | 165,081 | 49.8% |
| 2024-12-06 | 47,186 | 25 | 140,614 | 33.6% |
| 2024-12-05 | 41,690 | 2 | 103,658 | 40.2% |
| 2024-12-04 | 41,388 | 105 | 82,389 | 50.2% |
| 2024-12-03 | 71,059 | 11 | 116,511 | 61.0% |
| 2024-12-02 | 81,428 | 60 | 1,917,530 | 4.2% |
| 2024-11-29 | 56,655 | 292 | 121,946 | 46.5% |
| 2024-11-27 | 103,484 | 363 | 146,950 | 70.4% |
| 2024-11-26 | 95,433 | 39 | 111,264 | 85.8% |
| 2024-11-25 | 78,430 | 298 | 111,935 | 70.1% |
| 2024-11-22 | 83,961 | 16 | 99,175 | 84.7% |
| 2024-11-21 | 51,160 | 230 | 81,776 | 62.6% |
| 2024-11-20 | 57,988 | 118 | 89,327 | 64.9% |
| 2024-11-19 | 37,413 | 0 | 67,306 | 55.6% |
| 2024-11-18 | 57,206 | 0 | 85,259 | 67.1% |
| 2024-11-15 | 68,991 | 70 | 92,924 | 74.2% |
| 2024-11-14 | 36,331 | 1 | 49,413 | 73.5% |
| 2024-11-13 | 57,883 | 1 | 95,244 | 60.8% |
| 2024-11-12 | 77,341 | 0 | 128,593 | 60.1% |
| 2024-11-11 | 41,851 | 220 | 62,226 | 67.3% |
| 2024-11-08 | 31,720 | 0 | 59,183 | 53.6% |
| 2024-11-07 | 22,179 | 0 | 42,892 | 51.7% |
| 2024-11-06 | 91,583 | 52 | 190,943 | 48.0% |
| 2024-11-05 | 69,396 | 2 | 97,702 | 71.0% |
| 2024-11-04 | 29,473 | 2 | 61,372 | 48.0% |
| 2024-11-01 | 31,516 | 15 | 81,008 | 38.9% |
| 2024-10-31 | 34,238 | 13 | 82,617 | 41.4% |
| 2024-10-30 | 86,721 | 4 | 365,245 | 23.7% |
| 2024-10-29 | 41,911 | 0 | 66,801 | 62.7% |
| 2024-10-28 | 25,816 | 186 | 46,386 | 55.7% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.